ClinicalTrials.govpublic full text
Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide
metastatic breast cancer, solid tumor, breast cancer, metastatic cancer, pembrolizumab, metronomic cyclophosphamide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902685
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.